Additionally, it is worth noting that, as an independent risk factor for rapid disease progression of CLL patients, decreased TCF1 and BCL11B expression coincided with high-risk indicators for CLL, including unmutated IGHV and TP53 aberration. This evidence concerns the gene TCF7 and B-cell chronic lymphocytic leukemia.